Compounds > quinazolines

Page last updated: 2024-08-21

quinazolines and Folliculitis

quinazolines has been researched along with Folliculitis in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	10 (62.50)	29.6817
2010's	6 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Keith, DJ; Stewart, DG	1
Ena, L; Ena, P; Fadda, GM; Farris, A; Santeufemia, DA	1
Acharya, J; Bottomley, DM; Lyon, C	1
Brown, CW; Campbell, TM	1
Aractingi, S; Nassar, D; Soutou, B	1
Drillenburg, P; Hoekzema, R	1
Becker, A; Postmus, PE; Smit, EF; van Wijk, A	1
Liu, D; Shentu, J; Tan, F; Wang, Y; Xu, N; Yang, G; Yao, Y; Zhao, Q; Zhou, J	1
Arnault, JP; Baudin, E; Brassard, M; Giacchero, D; Maksimovic, L; Mateus, C; Ramacciotti, C; Robert, C; Schlumberger, M; Tomasic, G; Wechsler, J	1
Wang, B; Wang, YN; Zhao, Q	1
Aguilar, A; Aspiroz, C; Cuétara, MS; del Palacio, A; Martin, L	1
Iijima, M; Kitami, A; Nakada, T; Sagara, R	1
Gerdes, S; Mrowietz, U	1
Burkhart, C; Matheis, P; Socinski, MA; Thomas, NE; Warren, S	1
Al Hammadi, A; Gerstein, W; Tangri, N	1
Nguyen, D; Parr, AL; Steinberg, SM; Tan, AR; Yang, SX	1

Trials

3 trial(s) available for quinazolines and Folliculitis

Article	Year
Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 73, Issue:2 Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Crown Ethers; ErbB Receptors; Female; Folliculitis; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Proto-Oncogene Proteins p21(ras); Quinazolines; Treatment Outcome	2011
A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib. Archives of dermatology, 2012, Volume: 148, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Female; Folliculitis; Hand-Foot Syndrome; Humans; Hyperpigmentation; Male; Middle Aged; Photosensitivity Disorders; Piperidines; Protein Kinase Inhibitors; Quinazolines; Thyroid Neoplasms	2012
Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1 Topics: Acneiform Eruptions; Antineoplastic Agents; Biomarkers; Biopsy; Breast Neoplasms; Carcinoma; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Folliculitis; Gene Expression Profiling; Humans; Ki-67 Antigen; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin	2008

Other Studies

13 other study(ies) available for quinazolines and Folliculitis

Article	Year
Erlotinib-induced folliculitis decalvans. Clinical and experimental dermatology, 2013, Volume: 38, Issue:8 Topics: Aged; Anti-Infective Agents; Drug Therapy, Combination; Erlotinib Hydrochloride; Folliculitis; Glucocorticoids; Humans; Male; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome	2013
Tufted hair folliculitis in a woman treated with lapatinib for breast cancer. Clinical and experimental dermatology, 2008, Volume: 33, Issue:6 Topics: Alopecia; Antineoplastic Agents; Breast Neoplasms; Female; Folliculitis; Granuloma, Pyogenic; Humans; Lapatinib; Middle Aged; Quinazolines	2008
Folliculitis-perifolliculitis related to erlotinib therapy spares previously irradiated skin. Journal of the American Academy of Dermatology, 2009, Volume: 60, Issue:1 Topics: Adult; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Folliculitis; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines; Skin	2009
Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:12 Topics: Acneiform Eruptions; Aged; Drug Eruptions; Erlotinib Hydrochloride; Folliculitis; Humans; Male; Protein Kinase Inhibitors; Psoriasis; Quinazolines	2008
[Cutaneous side effects of EGF receptor inhibitors]. Bulletin du cancer, 2009, Volume: 96 Suppl Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Folliculitis; Gefitinib; Humans; Nail Diseases; Panitumumab; Quinazolines; Skin	2009
Folliculitis decalvans associated with erlotinib. Clinical and experimental dermatology, 2010, Volume: 35, Issue:8 Topics: Alopecia; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Folliculitis; Humans; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Staphylococcus aureus	2010
Side-effects of long-term administration of erlotinib in patients with non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010, Volume: 5, Issue:9 Topics: Adenocarcinoma; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Diarrhea; ErbB Receptors; Erlotinib Hydrochloride; Fatigue; Female; Folliculitis; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Paronychia; Protein Kinase Inhibitors; Quinazolines; Time Factors; Treatment Outcome	2010
Spared pre-irradiated area in pustular lesions induced by icotinib showing decreased expressions of CD1a+ langerhans cells and FGFR2. Japanese journal of clinical oncology, 2013, Volume: 43, Issue:2 Topics: Acneiform Eruptions; Adenocarcinoma; Adenocarcinoma of Lung; Antigens, CD1; Antineoplastic Agents; Biopsy; Blister; Chemotherapy, Adjuvant; Crown Ethers; Dose Fractionation, Radiation; Down-Regulation; Drug Eruptions; Enzyme Inhibitors; ErbB Receptors; Face; Folliculitis; Humans; Immunohistochemistry; Ki-67 Antigen; Langerhans Cells; Lung Neoplasms; Male; Middle Aged; Protein-Tyrosine Kinases; Quinazolines; Receptor, Fibroblast Growth Factor, Type 2; Skin; Thoracic Wall	2013
Erlotinib associated with rosacea-like folliculitis and Malassezia sympodialis. The British journal of dermatology, 2006, Volume: 155, Issue:2 Topics: Aged; Antineoplastic Agents; Dermatomycoses; Drug Eruptions; Erlotinib Hydrochloride; Folliculitis; Humans; Malassezia; Male; Quinazolines; Rosacea	2006
Adverse reactions to gefitinib (Iressa): revealing sycosis- and pyoderma gangrenosum-like lesions. International journal of dermatology, 2006, Volume: 45, Issue:8 Topics: Antineoplastic Agents; Folliculitis; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Pyoderma Gangrenosum; Quinazolines	2006
Follicular rash during therapy with erlotinib (Tarceva). Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2006, Volume: 4, Issue:10 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Facial Dermatoses; Folliculitis; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Pruritus; Quinazolines; Treatment Outcome	2006
Treatment of gefitinib-associated folliculitis. Journal of the American Academy of Dermatology, 2006, Volume: 55, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Folliculitis; Gefitinib; Humans; Male; Middle Aged; Quinazolines	2006
Epidermal growth factor receptor inhibitor-related folliculitis. Dermatitis : contact, atopic, occupational, drug, 2007, Volume: 18, Issue:3 Topics: Aged; Carcinoma, Non-Small-Cell Lung; Diagnosis, Differential; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Face; Folliculitis; Humans; Lung Neoplasms; Male; Neck; Protein Kinase Inhibitors; Quinazolines	2007